Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H9NO |
| Molecular Weight | 87.1204 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(N)=O
InChI
InChIKey=DNSISZSEWVHGLH-UHFFFAOYSA-N
InChI=1S/C4H9NO/c1-2-3-4(5)6/h2-3H2,1H3,(H2,5,6)
| Molecular Formula | C4H9NO |
| Molecular Weight | 87.1204 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 1-(4-Bromo-phen-yl)-3-butano-ylthio-urea. | 2010-12-08 |
|
| Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. | 2010-12-06 |
|
| Synthesis of the sponge-derived plakortone series of bioactive compounds. | 2010-10-01 |
|
| Dimeric supramolecular motifs of two carboxylate-guanidinium compounds. | 2010-09 |
|
| Direct assay of delta-aminolevulinic acid dehydratase in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry. | 2010-08-01 |
|
| A new acylamidase from Rhodococcus erythropolis TA37 can hydrolyze N-substituted amides. | 2010-08 |
|
| Structure-activity relationships of 33 carboxamides as toxicants against female Aedes aegypti (Diptera: Culicidae). | 2010-03 |
|
| 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields. | 2010-02 |
|
| Sensitive and specific enzyme immunoassays for antigenic trisaccharide from Bacillus anthracis spores. | 2009-12-21 |
|
| N-(3,4-Dichloro-phen-yl)-3-oxo-butanamide. | 2009-12-04 |
|
| An analytic potential energy function for the amide-amide and amide-water intermolecular hydrogen bonds in peptides. | 2009-11-30 |
|
| Effect of the regiochemistry of butyl amide substituents on the solution-state structures of lanthanide(III) DOTA-tetraamide complexes. | 2009-11-02 |
|
| Synthesis, cytotoxicity by bioluminescence inhibition, antibacterial and antifungal activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic acid amides. | 2009-11 |
|
| Advances in marine microbial symbionts in the china sea and related pharmaceutical metabolites. | 2009-04-20 |
|
| 2-(4-Chloro-phen-yl)-3-methyl-N-(5-methyl-thia-zol-2-yl)butanamide. | 2008-12-20 |
|
| Aluminum-catalyzed asymmetric alkylations of pyridyl-substituted alkynyl ketones with dialkylzinc reagents. | 2008-07-30 |
|
| Chili pepper fruits: presumed precursors of fatty acids characteristic for capsaicinoids. | 2008-06-11 |
|
| Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins. | 2008-05 |
|
| R-stereoselective amidase from Rhodococcus erythropolis No. 7 acting on 4-chloro-3-hydroxybutyramide. | 2008-03 |
|
| N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy. | 2008-01 |
|
| Selective androgen receptor modulators in preclinical and clinical development. | 2008 |
|
| Synthesis of DL-fluorobenzenamides as anticonvulsants. | 2008 |
|
| [Preprocessing of collagenous sources with the aim of extracting minimally denatured collagen]. | 2007-11-07 |
|
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. | 2007-08-23 |
|
| Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands. | 2007-07-07 |
|
| Total solid-phase synthesis of bombesin analogs with different functional groups at the C-terminus. | 2007-07 |
|
| Comparative transport efficiencies of urea analogues through urea transporter UT-B. | 2007-07 |
|
| Reduction of site-specific CYP3A-mediated metabolism for dual angiotensin and endothelin receptor antagonists in various in vitro systems and in cynomolgus monkeys. | 2007-05 |
|
| 3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes. | 2007-03-01 |
|
| Bioconversion of butyronitrile to butyramide using whole cells of Rhodococcus rhodochrous PA-34. | 2007-03 |
|
| [State of intracellular signaling systems in endothelial dysfunction]. | 2007 |
|
| Future therapeutic treatment of COPD: struggle between oxidants and cytokines. | 2007 |
|
| Gastroprotective activity and cytotoxic effect of cyperenoic acid derivatives. | 2006-11 |
|
| 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties. | 2006-09-15 |
|
| Involvement of basal protein kinase C and extracellular signal-regulated kinase 1/2 activities in constitutive internalization of AMPA receptors in cerebellar Purkinje cells. | 2006-05-03 |
|
| Distributed polarizabilities obtained using a constrained density-fitting algorithm. | 2006-01-14 |
|
| Solvent friction effect on intramolecular electron transfer. | 2005-12-21 |
|
| Synthesis of uniform protein-polymer conjugates. | 2005-11-15 |
|
| Application of Fourier transform infrared spectroscopy for monitoring hydrolysis and synthesis reactions catalyzed by a recombinant amidase. | 2005-11-01 |
|
| Activity coefficients and thermodynamic parameters for RbCl/CsCl + amide (acetamide, propanamide, and n-butanamide) + water system at 298.15 K. | 2005-10-22 |
|
| Transferable potentials for phase equilibria. 7. Primary, secondary, and tertiary amines, nitroalkanes and nitrobenzene, nitriles, amides, pyridine, and pyrimidine. | 2005-10-13 |
|
| Identification of dielectric and structural relaxations in glass-forming secondary amides. | 2005-08-01 |
|
| Purification and characterization of a serine alkaline protease from Bacillus clausii GMBAE 42. | 2005-08 |
|
| Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity. | 2005-01-03 |
|
| Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage. | 2004-11-26 |
|
| Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity. | 2004-08-12 |
|
| Sterically and guest-controlled self-assembly of calix[4]arene derivatives. | 2004-05-03 |
|
| 4-Substituted anilides as selective melatonin MT2 receptor agonists. | 2004-02-23 |
|
| General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways. | 2003 |
|
| Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways. | 2003 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:24:59 GMT 2025
by
admin
on
Mon Mar 31 19:24:59 GMT 2025
|
| Record UNII |
9J6OR937VR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
BUTYRAMIDE
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C006866
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
50724
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
10927
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
DB02121
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
1653515
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | RxNorm | ||
|
BUTYRAMIDE
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
1582
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
208-776-4
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
m2866
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
8424
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
5684
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
541-35-5
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
100000163191
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
SUB177334
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
9J6OR937VR
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY | |||
|
DTXSID8060248
Created by
admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
|
PRIMARY |